Medical News

RSS

Requirement for pediatric cardiac devices highlighted by off-label procedures

Nearly two-thirds of children who undergo routine interventional cardiology procedures -- those involving a catheter to treat structural disorders of the heart -- may be receiving treatment with a device that's being used for an off-label application.

30 Mar 2009

Study examines drug delivery systems activated by light

A study published in a special issue of Photochemistry and Photobiology examines the emerging practice of drug delivery systems which use the application of light to activate medications in the body.

30 Mar 2009

Study examines effect of heart surgery on employment

A new studying appearing in Congenital Heart Disease compares the careers and long-term occupational successes of men and women who underwent surgery for congenital heart disease to those of the general population.

30 Mar 2009

Study answers question of timing in use of eptifibatide

An international study to resolve a decade of debate over the best timing for administering an anti-clotting drug for certain heart patients has come up with an answer: It doesn't matter.

30 Mar 2009

Genetic engineering breakthrough

In a genetic engineering breakthrough that could help everyone from bed-ridden patients to elite athletes, a team of American researchers - including 2007 Nobel Prize winner Mario R. Capecchi - have created a "switch" that allows mutations or light signals to be turned on in muscle stem cells to monitor muscle regeneration in a living mammal

30 Mar 2009

Discovery of new role for certain lung cells in the immune response to airborne allergens

Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and at Ghent University in Ghent, Belgium, have identified a new role for certain lung cells in the immune response to airborne allergens.

30 Mar 2009

SARcode announces results of phase 1 trial of SAR 1118 ophthalmic solution in healthy adult subjects

SARcode Corporation announced today the results of its Phase 1 randomized, double-masked, placebo-controlled trial of the safety, tolerability, and pharmacokinetics of single- and multiple-escalating doses of SAR 1118 Ophthalmic Solution in healthy volunteers.

30 Mar 2009

The use of native African plants in veterinary medicine studied by K-State researchers

When animals in southern Africa are sick, often the first place their caretakers look for help is from native plants.

30 Mar 2009

Schizophrenics at increased risk for type 2 diabetes

People with schizophrenia are at increased risk for type 2 diabetes, Medical College of Georgia researchers have found.

30 Mar 2009

New brain mapping capabilities come to desktops of scientists worldwide

Mapping the billions of connections in the brain is a grand challenge in neuroscience.

30 Mar 2009

Protecting the public from food-borne illness and food associated hazards are main goal as addressed by food scientist

At the Institute of Medicine (IOM) and National Research Council (NRC) meeting held on March 24, Institute of Food Technologists (IFT) food scientist Dr. Frank Busta addressed food safety gaps in the Food Protection Plan by the U.S. Food and Drug Administration (FDA).

30 Mar 2009

A genetic technique to distinguish benign moles from malignant melanomas

A UCSF research team has developed a technique to distinguish benign moles from malignant melanomas by measuring differences in levels of genetic markers.

30 Mar 2009

New radiation-free targeted therapy detects and eliminates breast cancer tumors in mice

Combining a compound known as a gallium corrole with a protein carrier results in a targeted cancer therapy that is able to detect and eliminate tumors in mice with seemingly fewer side effects than other breast-cancer treatments, says a team of researchers from the California Institute of Technology (Caltech), the Israel Institute of Technology (Technion) and the Cedars-Sinai Medical Center.

30 Mar 2009

New, more effective nisin antibiotics combat superbugs and food diseases

Researchers at University College Cork have used bioengineering to produce a new generation of natural antibiotics that target harmful micro-organisms such as MRSA and the food-borne pathogen, Listeria monocytogenes

30 Mar 2009

Research helps explain how chronic liver damage can eventually lead to cancer

Liver damage can be triggered by various insults, including hepatitis infection or alcohol-induced cirrhosis.

30 Mar 2009

Fancy French gluten-free bread for celiac disease sufferers

Gluten-free bread, which is suitable for patients with celiac disease, has been supplemented to resemble French bread in terms of texture and color, according to a study in the Journal of Food Science, published by the Institute of Food Technologists (IFT).

30 Mar 2009

In lab supplements of lipoic acid lower triglyceride levels

Studies done with laboratory rats suggest that supplementation of their diet with lipoic acid had a significant effect in lowering triglycerides, which along with cholesterol levels and blood pressure are one of the key risk factors in cardiovascular disease.

30 Mar 2009

Mylan's Matrix receives tentative FDA approval under PEPFAR for generic Truvada

Mylan Inc. has announced that Matrix Laboratories Limited, its India-based subsidiary in which it holds a 71.2% controlling interest, has received the first tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg.

30 Mar 2009

Mutations within a conservative region of hepatitis C virus affect therapy

At least 200 million individuals are currently infected with hepatitis C virus (HCV) worldwide.

30 Mar 2009

Multiple sclerosis associated with lower cancer risk overall

A new study shows that people with multiple sclerosis may be at a lower risk for cancer overall, but at a higher risk of developing certain types of cancer, such as brain tumors and bladder cancer.

30 Mar 2009